Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled
its first quarter 2015 financial results conference call for 8:00 a.m.
ET on Thursday, April 30, 2015. The schedule for the press release and
conference call is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• Q1 2015 Press Release:
|
|
|
|
|
|
April 30, 2015 at 7:00 a.m. ET
|
|
|
|
|
|
|
• Q1 2015 Conference Call:
|
|
|
|
|
|
April 30, 2015 at 8:00 a.m. ET
|
|
|
|
|
|
|
• Domestic Dial-In Number:
|
|
|
|
|
|
877-407-8037
|
|
|
|
|
|
|
• International Dial-In Number:
|
|
|
|
|
|
201-689-8037
|
|
|
|
|
|
|
• Conference ID Number:
|
|
|
|
|
|
13604399
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If you are unable to participate, a replay of the conference call will
be available for thirty days. The replay dial-in number for the U.S. is
877-660-6853 and the dial-in number for international callers is
201-612-7415. To access the replay you will need the conference ID
number 13604399.
The conference call will also be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary therapeutics, primarily for oncology. For additional
information on Incyte, please visit the Company's web site at www.incyte.com.
Copyright Business Wire 2015